A sensitive method for the quantification of fluticasone propionate in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionisation mass spectrometry
- 1 November 1997
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 16 (3) , 447-452
- https://doi.org/10.1016/s0731-7085(97)00073-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Determination of epimers 22R and 22S of budesonide in human plasma by high-performance liquid chromatography—atmospheric pressure chemical ionization mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Pharmacokinetics of intravenous fluticasone propionate in healthy subjectsBritish Journal of Clinical Pharmacology, 1996
- Fluticasone propionate — an update on preclinical and clinical experienceRespiratory Medicine, 1995
- New perspectives on inhaled drug delivery and systemic bioactivity.Thorax, 1995
- A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects [see comments]British Journal of Clinical Pharmacology, 1994
- An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers [see comments]Published by Wiley ,1994
- A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasmaJournal of Pharmaceutical and Biomedical Analysis, 1993
- Determination of (22R,S)budesonide in human plasma by automated liquid chromatography/thermospray mass spectrometryJournal of Mass Spectrometry, 1992
- Increasing thermospray response for cortisol by derivatizationJournal of Chromatography A, 1991
- The human pharmacology of fluticasone propionateRespiratory Medicine, 1990